Login/Register

BioCode Respiratory Pathogen Panel

Taiwan
Partnership wanted
Introduction
Detect the common pathogens causing respiratory infection, including virus and bacteria. Run with Automated System BioCode MDx3000, can perform nucleic acid based diagnostics with centralized format, high sample volume, low cost, and automation. From naso swab sample, identify and detect simultaneously as many as 17 targets:
• Adenovirus • Coronavirus (229E, OC43, HKU1, and NL63) • Human Metapneumovirus A/B • Influenza A, including subtypes H1, H1 2009 Pandemic, and H3 • Influenza B • Parainfluenza 1 • Parainfluenza 2 • Parainfluenza 3 • Parainfluenza 4 • Respiratory Syncytial Virus A/B • Rhinovirus/Enterovirus • Bordetella pertussis • Chlamydia pneumoniae • Mycoplasma pneumoniae • Internal Control---MS2
Features / strengths
Flu is the most common illness. In US there are 35million flu symptom patients visits per year, and 18million are tested positive with flu pathogens. Clinical laboratories typically rely on the combination of conventional microbiological methods and molecular methods, and the full test may take 2-7 days to obtain results. The BioCode Respiratory Pathogen Panel gives physician a front line screening option base on the syndrome, rapidly and comprehensively tests against a full range of pathogens. Provides 17 test results for 96 patient samples, in 3.5 hour short turn around time. Can flexibly report or mask out pathogens. Can run concurrently with other Applied BioCode panels, drastically improve testing efficiency.
Specification in detail
Reaction
96 samples
TFDA Registration
034907
Supporting document

Information
Introduction
Detect the common pathogens causing respiratory infection, including virus and bacteria. Run with Automated System BioCode MDx3000, can perform nucleic acid based diagnostics with centralized format, high sample volume, low cost, and automation. From naso swab sample, identify and detect simultaneously as many as 17 targets:
• Adenovirus • Coronavirus (229E, OC43, HKU1, and NL63) • Human Metapneumovirus A/B • Influenza A, including subtypes H1, H1 2009 Pandemic, and H3 • Influenza B • Parainfluenza 1 • Parainfluenza 2 • Parainfluenza 3 • Parainfluenza 4 • Respiratory Syncytial Virus A/B • Rhinovirus/Enterovirus • Bordetella pertussis • Chlamydia pneumoniae • Mycoplasma pneumoniae • Internal Control---MS2
Features / strengths
Flu is the most common illness. In US there are 35million flu symptom patients visits per year, and 18million are tested positive with flu pathogens. Clinical laboratories typically rely on the combination of conventional microbiological methods and molecular methods, and the full test may take 2-7 days to obtain results. The BioCode Respiratory Pathogen Panel gives physician a front line screening option base on the syndrome, rapidly and comprehensively tests against a full range of pathogens. Provides 17 test results for 96 patient samples, in 3.5 hour short turn around time. Can flexibly report or mask out pathogens. Can run concurrently with other Applied BioCode panels, drastically improve testing efficiency.
Specification in detail
Reaction
96 samples
TFDA Registration
034907
Supporting document

BioCode Respiratory Pathogen Panel

Taiwan
Applied BioCode Other products
Recommended